News
Medtronic announced the treatment of the first patient in the United States in the Global SYMPLICITY Registry (GSR) DEFINE. The cl ...
Travere Therapeutics, Inc., today announced that the Company will present three abstracts on the effect of FILSPARI (sparsentan) in rare kidney disease at the upcoming International Podocyte ...
Spironolactone does not reduce the rate of cardiovascular death or heart failure in patients undergoing maintenance dialysis.
For patients with CKD and T2D, combination finerenone plus empagliflozin leads to a greater reduction in the urinary albumin-to-creatinine ratio than either agent alone.
New data from Phase 2 SPARTAN Study show antifibrotic and anti-inflammatory action of FILSPARI and its impact on B cell and complement pathways in IgAN Travere Therapeutics, Inc., (Nasdaq: TVTX) today ...
The presence of an abdominal murmur has been most extensively studied in hypertension secondary to stenosis of the renal artery. Murmurs are frequently present in such cases, but their diagnostic ...
To determine whether this characteristic heightens bleeding risk in patients with renal insufficiency, researchers in Connecticut compared bleeding rates with enoxaparin and UFH in a retrospective ...
A nephrologist is a doctor who specializes in treating diseases that affect the kidneys. You may need to see a nephrologist if you have chronic kidney disease, kidney infections, or kidney failure ...
penetrating trauma and blunt renal trauma. Blood passage from a lacerated artery to the renal parenchyma leads to RAP. The walls of a true aneurysm contain one or more of the original arterial coats ...
Additional influences of atherosclerosis, glucose regulation, chronic renal disease, salt, and changes in neurohormonal regulation are discussed. A review of the hemodynamic impact of arterial ...
The presence of coronary artery calcification, an established marker of subclinical atherosclerosis, has been shown to predict future risk of cardiovascular events and mortality. 1 Calcifications in ...
Objective Patients with renal failure suffer from symptoms caused by uraemic toxins, possibly of gut microbial origin, as deduced from studies in animals. The aim of the study is to characterise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results